Latest Insider Transactions at Inhibikase Therapeutics, Inc. (IKT)
This section provides a real-time view of insider transactions for Inhibikase Therapeutics, Inc. (IKT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inhibikase Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inhibikase Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2022
|
Milton H. Werner President and CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.09%
|
$0
$0.8 P/Share
|
|
May 27
2022
|
Milton H. Werner President and CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.09%
|
$0
$0.98 P/Share
|
|
May 20
2022
|
Milton H. Werner President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.19%
|
$0
$0.6 P/Share
|
|
May 19
2022
|
Joseph Frattaroli Cheif Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,948
+7.59%
|
$0
$0.64 P/Share
|
|
Jan 03
2022
|
Milton H. Werner President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,853
+0.41%
|
$43,706
$2.02 P/Share
|
|
Nov 17
2021
|
Milton H. Werner President and CEO |
BUY
Open market or private purchase
|
Indirect |
23,589
+13.21%
|
$23,589
$1.96 P/Share
|
|
Aug 17
2021
|
Milton H. Werner President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,853
+0.41%
|
$43,706
$2.02 P/Share
|
|
May 14
2021
|
Milton H. Werner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,918
-0.32%
|
$67,672
$4.59 P/Share
|
|
May 14
2021
|
Milton H. Werner President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
43,707
+0.82%
|
$0
$0.38 P/Share
|
|
Dec 28
2020
|
Joseph Frattaroli Cheif Financial Officer |
BUY
Conversion of derivative security
|
Indirect |
44,143
+50.0%
|
$441,430
$10.0 P/Share
|